Biotic Laboratories' mission is to develop a flexible drug delivery platform technology that can optimally release a variety of pharmaceuticals for cancer and immunology applications, thereby reducing toxicity, patient visits, and overall costs of production and administration.

June 2009: Biotic Laboratories sponsors the International Association of Nanotechnology meeting in San Francisco.

June 2009: Biotic Laboratories is awarded a Phase I Small Business Innovation Research Grant from the National Science Foundation.

Feb 2009: Biotic Laboratories establishes a sponsored research agreement with Dr. Paul Dempsey’s laboratory at the UCLA.